Endorsement of "European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea" by World Sleep Society.


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
28 Nov 2023
Historique:
received: 05 10 2023
accepted: 07 10 2023
medline: 13 12 2023
pubmed: 13 12 2023
entrez: 12 12 2023
Statut: aheadofprint

Résumé

Guidelines for management of sleep disorders from national or regional societies provide recommendations that may be regionally appropriate but may not always be practical or relevant in other parts of the world. A task force of experts from the World Sleep Society's (WSS) International Sleep Medicine Guidelines Committee and Sleep and Breathing Disorders Task Force reviewed the European Respiratory Society's guideline on non-CPAP therapies for obstructive sleep apnea (OSA) with respect to its relevance and applicability to the practice of sleep medicine by sleep specialists in various regions of the world. The task force and the WSS guidelines committee endorsed the European Respiratory Society's guideline with respect to the utilization of bariatric surgery, mandibular advancement devices, positioning devices, myofunctional therapy, hypoglossal neurostimulation, maxilo-mandibular surgery, and carbonic anhydrase inhibitors for the treatment of OSA. The task force and the WSS guidelines committee noted that there is substantial new evidence for the role of soft tissue, upper airway surgery, not included in the guidelines paper.

Identifiants

pubmed: 38086250
pii: S1389-9457(23)00372-6
doi: 10.1016/j.sleep.2023.10.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-298

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ofer Jacobowitz reports a relationship with LivaNova USA, Inc. That includes: consulting or advisory. Ofer Jacobowitz reports a relationship with Nyxoah SA that includes: consulting or advisory. Clete Kushida reports a relationship with Vivos Therapeutics that includes: consulting or advisory.

Auteurs

Ofer Jacobowitz (O)

Sleep Department, ENT and Allergy Associates, New York, NY, USA. Electronic address: ojacobowitz@entandallergy.com.

Lamia Afifi (L)

Clinical Neurophysiology, School of Medicine, Cairo University, Egypt.

Uri Alkan (U)

Department of Otorhinolaryngology - Head and Neck Surgery, Rabin Medical Center, Petach Tikva, Israel.

Thomas Penzel (T)

Interdisciplinary Sleep Medicine Center, Charite Universitatsmedizin Berlin, Germany.

Dalva Poyares (D)

Psychobiology Department, Sleep Medicine Division, Universidade Federal de Sao Paulo, Brazil.

Clete Kushida (C)

Sleep Clinic and Center for Human Sleep Research, Stanford University School of Medicine, Redwood City, CA, USA.

Classifications MeSH